Bristol-Myers Squibb (BMY) Tops Q4 EPS by 6c; Issues Light FY15 Outlook
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.65 --0%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $4.26 billion versus the consensus estimate of $4.02 billion.
Bristol-Myers Squibb sees FY2015 EPS of $1.55-$1.70, versus the consensus of $1.71.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Hot ListRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
